FDA authorizes at-home COVID test by Siemens Healthineers
The Food and Drug Administration on Wednesday granted an emergency use authorization to an at-home COVID-19 test made by German company Siemens Healthineers.
The highly contagious Delta and Omicron coronavirus variants are causing a surge in new cases across the United States, and several retailers, including CVS, Walgreens, and Walmart are limiting the number of at-home testing kits customers can purchase. The Siemens tests are expected to become available in January, and the company said its product can be used by children 2 and up as long as an adult collects the sample.
The Department of Health and Human Services said on Wednesday the Biden administration wants to get tens of millions of new tests into the U.S. every month, with the goal of distributing them for free to U.S. households.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Ukraine hints at end to 'hot war' with Russia in 2025
Talking Points Could the new year see an end to the worst European violence of the 21st Century?
By Rafi Schwartz, The Week US Published
-
What does the FDIC do?
In the Spotlight Deposit insurance builds confidence in the banking system
By Joel Mathis, The Week US Published
-
2024: The year of conspiracy theories
IN THE SPOTLIGHT Global strife and domestic electoral tensions made this year a bonanza for outlandish worldviews and self-justifying explanations
By Rafi Schwartz, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
The great departure: Texas OB-GYNs are leaving the Lone Star State
Under the radar The state is suffering an exodus of health care professionals, creating more maternity care deserts
By Theara Coleman, The Week US Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published